Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Malignant Peripheral Nerve Sheath Tumors (MPNSTs)
  • Journal: Current treatment options in oncology
  • Treatment Used: Systemic Treatment with First-Line Anthracycline-Based Therapy, Other Standard Cytotoxic Chemotherapy Agents
  • Number of Patients: 0
  • Published —
This article discusses systemic therapies for the treatment of patients with malignant peripheral nerve sheath tumors (MPNSTs).
  • Condition: Dermatofibrosarcoma Protuberance (DFSP)
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: Excision
  • Number of Patients: 306
  • Published —
This study clarified the effect of additional excision in the treatment of dermatofibrosarcoma protuberance (rare skin cancer; DFSP).
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 18
  • Start Date: April 2021
Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 400
  • Start Date: March 2021
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group